Latest News for 10/2017
19 Jul 2017
A scientific collaboration between researchers in Scotland and China has uncovered a new kind of `energy sensor’ in our cells, changing our understanding of how the body monitors glucose levels and switches on the supply of alternative `fuels’. It is thought the research, published in the journal Nature, could have particular implications for diabetes, in which the level of glucose in the blood is abnormally high.
19 Apr 2017
School of Life Sciences scientists have won a hat-trick of funding awards from the Wellcome Trust that will see more than £6million invested in their research. Professors Doreen Cantrell, Mark Field and Grahame Hardie have been successful in winning grants from Wellcome.
05 Jul 2016
Research led by the University of Dundee has found that one of a new breed of drugs, which have been approved for treatment of Type 2 diabetes, may be particularly effective without the need to be used in combination with the existing drug, metformin.
05 Feb 2013
A review in Nature by Grahame Hardie of the Division of Cell Signalling and Immunology at CLS and Luke O’Neill (Trinity College Dublin) suggests that AMPK-activating drugs have both anti-cancer and anti-inflammatory properties.
23 Apr 2012
Grahame Hardie’s news story about aspirin’s potential for preventing cancer has gone global.
19 Apr 2012
New research carried out by Professor Grahame Hardie at the College of Life Sciences could lead to new uses for one of the world’s oldest medicines.
26 Mar 2012
Professor Grahame Hardie, of the Division of Cell Signalling and Immunology has been awarded a Wellcome Trust Senior Investigator Award for his research into 'Non-canonical pathways for regulation of AMPK'.
26 Oct 2011
Researchers from the Universities of Leeds, Edinburgh and Dundee have shed new light on the way that the brain protects itself from harm when ‘running on empty’.
19 Aug 2008
Professor Grahame Hardie, of the University of Dundee, has been selected for the prestigious 2008 Rolf Luft Award, which he will receive later this month at a ceremony in Stockholm, Sweden. The award was created in 2000 in honour of Professor Rolf Luft, Sweden’s most famous endocrinologist, and is awarded by the famed Karolinska Institute and the Rolf Luft Foundation for Diabetes Research.
19 May 2008
Prof. Grahame Hardie received an Honorary Degree - Doctor Honoris Causa- from the Medical University of Bialystok, Poland in recognition of his work on the discovery of AMP-activated protein kinase, its role as a sensor of cellular energy status and as a target for drugs aimed at treatment of Type 2 diabetes.